AQR Capital Management - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 260 filers reported holding FATE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.8%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$705,771
-54.4%
332,911
+22.7%
0.00%
-66.7%
Q1 2023$1,546,974
+158.3%
271,399
+1658.0%
0.00%
+200.0%
Q1 2022$599,000
-61.8%
15,438
-42.5%
0.00%
-66.7%
Q4 2021$1,570,000
-26.7%
26,831
-25.7%
0.00%
-25.0%
Q3 2021$2,142,000
-35.3%
36,132
-5.2%
0.00%
-33.3%
Q2 2021$3,309,000
+18.6%
38,124
+12.6%
0.01%
+20.0%
Q1 2021$2,791,000
-13.1%
33,847
-4.2%
0.01%
-16.7%
Q4 2020$3,212,000
+98.4%
35,322
-12.8%
0.01%
+100.0%
Q3 2020$1,619,000
-4.7%
40,506
-18.1%
0.00%0.0%
Q2 2020$1,698,000
+45.6%
49,485
-5.7%
0.00%
+50.0%
Q1 2020$1,166,000
+211.8%
52,479
+175.0%
0.00%
Q4 2019$374,000
-18.5%
19,086
-35.5%
0.00%
-100.0%
Q3 2019$459,000
-24.6%
29,579
-1.3%
0.00%0.0%
Q2 2019$609,000
+2.7%
29,982
-11.2%
0.00%0.0%
Q1 2019$593,000
+19.1%
33,772
-13.0%
0.00%0.0%
Q4 2018$498,000
-35.2%
38,814
-17.8%
0.00%0.0%
Q3 2018$769,000
+43.7%
47,2070.0%0.00%0.0%
Q2 2018$535,000
+70.9%
47,207
+47.4%
0.00%
Q1 2018$313,00032,0370.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$197,709,00022.51%
Redmile Group, LLC 12,957,222$758,127,00017.24%
Grosvenor Holdings, L.L.C. 1,037,256$60,690,0006.28%
Casdin Capital, LLC 3,400,000$198,934,0005.61%
Ally Bridge Group (NY) LLC 270,000$15,798,0005.52%
DAFNA Capital Management LLC 372,160$21,775,0005.48%
Tri Locum Partners LP 142,032$8,310,0003.27%
Kynam Capital Management, LP 95,561$5,591,0002.99%
Artal Group S.A. 1,800,000$105,318,0002.86%
Bellevue Group AG 3,775,736$220,918,0002.28%
View complete list of FATE THERAPEUTICS INC shareholders